ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

WHO approves Sinopharm vaccine for emergency use

Health body's first greenlight for Chinese-made shot raises hopes for emerging-market access

A health worker holds a dose of Sinopharm's coronavirus vaccine, in Lima, Peru, on Feb. 9.   © Reuters

SHANGHAI -- One of China's COVID-19 vaccines gained crucial recognition Friday, nearly one year after its debut, as the World Health Organization approved the shot for emergency use.

The SARS-CoV-2 vaccine by China National Biotec Group (CNBG) -- a unit of state-owned Sinopharm -- joined five Western peers on the WHO's emergency list.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more